News
![View Marketing and Communications Partnership View Marketing and Communications Partnership](https://agospharma.com/wp-content/uploads/2021/02/affiliation-with-vivactis-450x320.jpg)
Marketing and Communications Partnership
We are today delighted to announce the launch of a new working partnership with Vivactis – the specialist International biomedical …
![View EMA Oncology Guidance View EMA Oncology Guidance](https://agospharma.com/wp-content/uploads/2021/02/ema-oncology-guidance-thumb-450x320.jpg)
EMA Oncology Guidance
The EMA guidance is always invaluable when designing a clinical development program for products destined for the European market, and …
![View Early Experiences with Scientific Advice through IRIS View Early Experiences with Scientific Advice through IRIS](https://agospharma.com/wp-content/uploads/2020/12/scientific-advice-through-IRIS-450x320.jpg)
Early Experiences with Scientific Advice through IRIS
We recently submitted a scientific advice (SA)/protocol assistance (PA) request via IRIS for a US based SME with an Orphan …
![View Brexit and the end of the transition period View Brexit and the end of the transition period](https://agospharma.com/wp-content/uploads/2020/11/post-transition-guidance-450x320.jpg)
Brexit and the end of the transition period
EU rules will no longer apply to most of the UK from 31st December 2020. But it’s not that simple! …
Scientific Advice through the EMA Regulatory & Scientific Information Management Platform from October 19th 2020
From October 19th this year, Scientific Advice applications will need to go through the EMA Regulatory and Scientific Information Platform …
The Changing Face of Pharma Communications Online Forum
We at Agos are looking forward to this online gathering of selected senior industry colleagues and expert guests from the …
![View SME in Europe View SME in Europe](https://agospharma.com/wp-content/uploads/2020/04/sme-in-europe-feature-450x320.jpg)
SME in Europe
Agos Pharma have just renewed the SME status of our Irish subsidiary. This means we can access the excellent benefits …
![View Borderline Medicines and Medical Devices View Borderline Medicines and Medical Devices](https://agospharma.com/wp-content/uploads/2020/04/borderline-medicines-feature-450x320.jpg)
Borderline Medicines and Medical Devices
A number of our USA clients have come to us for help in Europe when developing a medicinal product or …
![View Update on Clinical Trial Regulation “Application” View Update on Clinical Trial Regulation “Application”](https://agospharma.com/wp-content/uploads/2020/03/ctr-application-update-feature-image-450x320.jpg)
Update on Clinical Trial Regulation “Application”
The Clinical Trials Regulation will not be applied, and the Clinical Trial Directive will not be repealed, until full functionality …